Eye redness can be irritating and difficult to treat. This study aims to evaluate the effectiveness and safety of an investigational eye drop. This new and investigational eye drop may provide up to 8 hours of eye redness relief.
Adult participants may receive up to $1,000 while child participants may receive up to $1,750 for their involvement in six (6) study visits over a two-month period. To determine your eligibility, complete the form below, and our team will contact you.
You may qualify to participate if you:
You or your child are 5 years or older
You or your child have been experiencing chronic ocular redness
You or your child have used eye drops for eye redness in the last 6 months
You or your child have not undergone eye surgery in the last 6 months
If you qualify for this study, here is what you can expect:
Study Visits: You or your child will attend six study visits over approximately two months.
Compensation: Participants may receive up to $1,000 (Adults) or $1,750 (Children) for completing all study visits.
During these visits, you or your child will:
Undergo a thorough eye exam.
Answer questions about your ocular health and general medical history.
Be randomly assigned to receive either the investigational eye drop or a placebo.*
Additionally, there are other assessments that the study team will discuss with you in detail during your visits.
*A “placebo” looks just like the investigational drug but does not contain any active study product in it.
We are currently conducting this study at these locations. Take a look at our addresses below to find out if the study location is near you.
The study will last approximately two months, with six visits.
Taking part in any clinical study is entirely voluntary. Your decision whether to participate will not affect the medical care you currently receive or may receive in the future. If you qualify and opt to join the study, you have the freedom to withdraw at any time and for any reason.
Your personal and medical information is completely protected before, during and after the clinical trial process through the HIPAA (Health Insurance Portability and Accountability Act) Privacy Rule. You will also be informed of who has access to your personal information.
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.
